Nutrition and prevention of Alzheimer's dementia

Frontiers in Aging Neuroscience

Volumn 6, Issue OCT, 2014, Pages

  Swaminathan, Arun ^a   Jicha, Gregory A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer; Clinical trial; Nutrition; Prevention; Treatment

Indexed keywords

AC 1202; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CHOLINE; COCONUT OIL; CYANOCOBALAMIN; DIMEBON; DOCOSAHEXAENOIC ACID; FLAVONOID; FOLIC ACID; GINKGO BILOBA EXTRACT; HOMOCYSTEINE; HUPERZINE A; ICOSAPENTAENOIC ACID; LIPID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; OCTANOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE; SELEGILINE; THIOCTIC ACID; TRACE ELEMENT; UBIQUINONE; UNINDEXED DRUG; URIDINE; VITAMIN;

AGED; AGING; ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; CALORIC RESTRICTION; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; FLATULENCE; FOOD; HEALTH PROMOTION; HUMAN; MEDICAL FOOD; MEDITERRANEAN DIET; MEMORY; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; OUTCOMES RESEARCH; OXIDATIVE STRESS; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84909633352     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00282     Document Type: Review

References (88)

1. Aggarwal, B. B. (2010). Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr. 30, 173-199. doi: 10.1146/annurev.nutr.012809.104755
2. Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F.,et al. (2008). High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783. doi: 10.1001/jama.300.15.1774
3. Anekonda, T. S. (2006). Resveratrol - a boon for treating Alzheimer's disease? Brain Res. Rev. 52, 316-326. doi: 10.1016/j.brainresrev.2006.04.004
4. Anekonda, T. S., and Reddy, P. H. (2006). Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem. 96, 305-313. doi: 10.1111/j.1471-4159.2005.03492.x
5. Baum, L., Lam, C. W., Cheung, S. K., Kwok, T., Lui, V., Tsoh, J.,et al. (2008). Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28, 110-113. doi: 10.1097/jcp.0b013e318160862c
6. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A.,et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342. doi: 10.1038/nature05354
7. Bhagavan, H. N., and Chopra, R. K. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 40, 445-453. doi: 10.1080/10715760600617843
8. Bharadwaj, P. R., Bates, K. A., Porter, T., Teimouri, E., Perry, G., Steele, J. W.,et al. (2013). Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Transl. Psychiatry 3:e332. doi: 10.1038/tp.2013.97
9. Bowman, G. L. (2012). Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction. Biofactors 38, 114-122. doi: 10.1002/biof.1002
10. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191. doi: 10.1016/j.jalz.2007.04.381
11. Cardoso, B. R., Cominetti, C., and Cozzolino, S. M. (2013). Importance and management of micronutrient deficiencies in patients with Alzheimer's disease. Clin. Interv. Aging 8, 531-542. doi: 10.2147/CIA.S27983
12. Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A.,et al. (2005). Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 81, 341-354.
13. Craft, S., Cholerton, B., and Baker, L. D. (2013). Insulin and Alzheimer's disease: untangling the web. J. Alzheimers Dis. 33(Suppl. 1), S263-S275. doi: 10.3233/JAD-2012-129042
14. Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S.,et al. (2011). Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27, 3-20. doi: 10.1016/j.nut.2010.07.021
15. Dangour, A. D., Whitehouse, P. J., Rafferty, K., Mitchell, S. A., Smith, L., Hawkesworth, S.,et al. (2010). B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J. Alzheimers Dis. 22, 205-224. doi: 10.3233/JAD-2010-090940
16. Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S. Jr., Cox, N. J.,et al. (2010). NIH state-of-the-science conference statement: preventing Alzheimer's disease and cognitive decline. NIH Consens. State Sci. Statements 27, 1-30.
17. Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R.,et al. (2011). Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch. Neurol. 68, 1185-1190. doi: 10.1001/archneurol.2011.100
18. de la Monte, S. M., and Tong, M. (2014). Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem. Pharmacol. 88, 548-559. doi: 10.1016/j.bcp.2013.12.012
19. DeDea, L. (2012). Can coconut oil replace caprylidene for Alzheimer disease? JAAPA 25:19. doi: 10.1097/01720610-201208000-00002
20. DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A.,et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300, 2253-2262. doi: 10.1001/jama.2008.683
21. Doody, R. S. (2009). Dimebon as a potential therapy for Alzheimer's disease. CNS Spectr. 14(8Suppl. 7), 14-16; discussion 16-18.
22. Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., Nichols, T. E., Smith, S. M.,et al. (2013). Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. U.S.A. 110, 9523-9528. doi: 10.1073/pnas.1301816110
23. Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M.,et al. (2014). Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311, 33-44. doi: 10.1001/jama.2013.282834
24. Fang, L., Gou, S., Liu, X., Cao, F., and Cheng, L. (2014). Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives. Bioorg. Med. Chem. Lett. 24, 40-43. doi: 10.1016/j.bmcl.2013.12.011
25. Feart, C., Samieri, C., and Barberger-Gateau, P. (2010). Mediterranean diet and cognitive function in older adults. Curr. Opin. Clin. Nutr. Metab. Care 13, 14-18. doi: 10.1097/MCO.0b013e3283331fe4
26. Filipcik, P., Cente, M., Ferencik, M., Hulin, I., and Novak, M. (2006). The role of oxidative stress in the pathogenesis of Alzheimer's disease. Bratisl. Lek. Listy 107, 384-394. doi: 10.4172/2161-0460.1000116
27. Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A.,et al. (2006). Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63, 1402-1408. doi: 10.1001/archneur.63.10.1402
28. Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D.,et al. (2010). Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res. Rev. 9, 399-417. doi: 10.1016/j.arr.2010.04.007
29. Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A.,et al. (2012). Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69, 836-841. doi: 10.1001/archneurol.2012.85
30. Gillette-Guyonnet, S., Secher, M., and Vellas, B. (2013). Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br. J. Clin. Pharmacol. 75, 738-755. doi: 10.1111/bcp.12058
31. Gillette-Guyonnet, S., and Vellas, B. (2008). Caloric restriction and brain function. Curr. Opin. Clin. Nutr. Metab. Care 11, 686-692. doi: 10.1097/MCO.0b013e328313968f
32. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A.,et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752. doi: 10.1161/CIRCULATIONAHA.105.169404
33. Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., and Costantini, L. C. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 6:31. doi: 10.1186/1743-7075-6-31
34. Hidaka, T., Fujii, K., Funahashi, I., Fukutomi, N., and Hosoe, K. (2008). Safety assessment of coenzyme Q10 (CoQ10). Biofactors 32, 199-208. doi: 10.1002/biof.5520320124
35. Hu, N., Yu, J. T., Tan, L., Wang, Y. L., Sun, L., and Tan, L. (2013). Nutrition and the risk of Alzheimer's disease. Biomed. Res. Int. 2013:524820. doi: 10.1155/2013/524820
36. Huang, X. T., Qian, Z. M., He, X., Gong, Q., Wu, K. C., Jiang, L. R.,et al. (2014). Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease. Neurobiol. Aging 35, 1045-1054. doi: 10.1016/j.neurobiolaging.2013.11.004
37. Jicha, G. A., and Carr, S. A. (2010). Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J. Alzheimers Dis. 19, 253-272. doi: 10.3233/JAD-2010-1237
38. Jicha, G. A., and Markesbery, W. R. (2010). Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin. Interv. Aging 5, 45-61. doi: 10.2147/CIA.S5231
39. Kamphuis, P. J., and Scheltens, P. (2010). Can nutrients prevent or delay onset of Alzheimer's disease? J. Alzheimers Dis. 20, 765-775. doi: 10.3233/JAD-2010-091558
40. Kamphuis, P. J., Verhey, F. R., Olde Rikkert, M. G., Twisk, J. W., Swinkels, S. H., and Scheltens, P. (2011). Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial. J. Nutr. Health Aging 15, 720-724. doi: 10.1007/s12603-011-0105-6
41. Kashiwaya, Y., Bergman, C., Lee, J. H., Wan, R., King, M. T., Mughal, M. R.,et al. (2013). A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol. Aging 34, 1530-1539. doi: 10.1016/j.neurobiolaging.2012.11.023
42. Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey-Bloom, J., Relkin, N.,et al. (2001). Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1143-1153. doi: 10.1212/WNL.56.9.1143
43. Kryscio, R. J., Abner, E. L., Schmitt, F. A., Goodman, P. J., Mendiondo, M., Caban-Holt, A.,et al. (2013). A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J. Nutr. Health Aging 17, 72-75. doi: 10.1007/s12603-013-0004-0
44. Lau, F. C., Shukitt-Hale, B., and Joseph, J. A. (2007). Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell. Biochem. 42, 299-318. doi: 10.1007/1-4020-5688-5_14
45. Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K.,et al. (2014). Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimers Dement. 10, 485-502. doi: 10.1016/j.jalz.2013.05.1771
46. Malaguarnera, M., Ferri, R., Bella, R., Alagona, G., Carnemolla, A., and Pennisi, G. (2004). Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin. Chem. Lab. Med. 42, 1032-1035. doi: 10.1515/CCLM.2004.208
47. Masse, I., Bordet, R., Deplanque, D., Al Khedr, A., Richard, F., Libersa, C.,et al. (2005). Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 76, 1624-1629. doi: 10.1136/jnnp.2005.063388
48. Miller, E. R. III, Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., and Guallar, E. (2005). Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37-46. doi: 10.7326/0003-4819-142-1-200501040-00110
49. Monti, M. C., Margarucci, L., Tosco, A., Riccio, R., and Casapullo, A. (2011). New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component. Food Funct. 2, 423-428. doi: 10.1039/c1fo10064e
50. Morris, M. S. (2002). Folate, homocysteine, and neurological function. Nutr. Clin. Care 5, 124-132. doi: 10.1046/j.1523-5408.2002.t01-1-00006.x
51. Morris, M. S. (2003). Homocysteine and Alzheimer's disease. Lancet Neurol. 2, 425-428. doi: 10.1016/S1474-4422(03)00438-1
52. Morris, M. S. (2012). The role of B vitamins in preventing and treating cognitive impairment and decline. Adv. Nutr. 3, 801-812. doi: 10.3945/an.112.002535
53. Nishida, Y., Yokota, T., Takahashi, T., Uchihara, T., Jishage, K., and Mizusawa, H. (2006). Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem. Biophys. Res. Commun. 350, 530-536. doi: 10.1016/j.bbrc.2006.09.083
54. Panza, F., Frisardi, V., Capurso, C., Imbimbo, B. P., Vendemiale, G., Santamato, A.,et al. (2010). Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J. Alzheimers Dis. 21, 691-724. doi: 10.3233/JAD-2010-091669
55. Pasinetti, G. M., and Eberstein, J. A. (2008). Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J. Neurochem. 106, 1503-14. doi: 10.1111/j.1471-4159.2008.05454.x
56. Pervaiz, S., and Holme, A. L. (2009). Resveratrol: its biologic targets and functional activity. Antioxid. Redox Signal. 11, 2851-2897. doi: 10.1089/ars.2008.2412
57. Pocernich, C. B., Lange, M. L., Sultana, R., and Butterfield, D. A. (2011). Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr. Alzheimer Res. 8, 452-469. doi: 10.2174/156720511796391908
58. Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C.,et al. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304, 1903-1911. doi: 10.1001/jama.2010.1510
59. Rafii, M. S., Walsh, S., Little, J. T., Behan, K., Reynolds, B., Ward, C.,et al. (2011). A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76, 1389-1394. doi: 10.1212/WNL.0b013e318216eb7b
60. Rao, A. V., and Balachandran, B. (2002). Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5, 291-309. doi: 10.1080/1028415021000033767
61. Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S.,et al. (2004). Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging 25, 311-314. doi: 10.1016/S0197-4580(03)00087-3
62. Ringman, J. M., Cole, G. M., Tend, E., Badmaev, V., Bardens, J., Frautschy, S.,et al. (2008). "Oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study," in Proceedings of the International Conference on Alzheimer's Disease, Chicago, IL.
63. Rockwood, K. (2006). Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol. Scand. Suppl. 185, 71-77. doi: 10.1111/j.1600-0404.2006.00688.x
64. Rubio-Perez, J. M., and Morillas-Ruiz, J. M. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012:756357. doi: 10.1100/2012/756357
65. Sano, M., Bell, K. L., Galasko, D., Galvin, J. E., Thomas, R. G., van Dyck, C. H.,et al. (2011). A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 77, 556-563. doi: 10.1212/WNL.0b013e318228bf11
66. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M.,et al. (1997). A controlled trial of selegiline, a-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336, 1216-1222. doi: 10.1056/NEJM199704243361704
67. Scarmeas, N., Luchsinger, J. A., Mayeux, R., and Stern, Y. (2007). Mediterranean diet and Alzheimer disease mortality. Neurology 69, 1084-1093. doi: 10.1212/01.wnl.0000277320.50685.7c
68. Scarmeas, N., Stern, Y., Tang, M. X., Mayeux, R., and Luchsinger, J. A. (2006). Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 59, 912-921. doi: 10.1002/ana.20854
69. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B.,et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483. doi: 10.1056/NEJMoa011613
70. Shah, R. (2013). The role of nutrition and diet in Alzheimer disease: a systematic review. J. Am. Med. Dir. Assoc. 14, 398-402. doi: 10.1016/j.jamda.2013.01.014
71. Shah, R. C., Kamphuis, P. J., Leurgans, S., Swinkels, S. H., Sadowsky, C. H., Bongers, A.,et al. (2013). The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease. Alzheimers Res. Ther. 5:59. doi: 10.1186/alzrt224
72. Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M., Ives, D. G., Rapp, S. R.,et al. (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 302, 2663-2670. doi: 10.1001/jama.2009.1913
73. Sofi, F., Macchi, C., Abbate, R., Gensini, G. F., and Casini, A. (2010). Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease? J. Alzheimers Dis. 20, 795-801. doi: 10.3233/JAD-2010-1418
74. Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P.,et al. (2011). Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev. Neurother. 11, 677-708. doi: 10.1586/ern.11.56
75. Solfrizzi, V., Scafato, E., Capurso, C., D'Introno, A., Colacicco, A. M., Frisardi, V.,et al. (2010). Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J. Neurol. Neurosurg. Psychiatry 81, 433-440. doi: 10.1136/jnnp.2009.181743
76. Tatton, W. G. (1993). Selegiline can mediate neuronal rescue rather than neuronal protection. Mov. Disord. 8(Suppl. 1), S20-S30. doi: 10.1002/mds.870080506
77. Thaipisuttikul, P., and Galvin, J. E. (2012). Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. Clin. Pract. (Lond.) 9, 199-209. doi: 10.2217/cpr.12.3
78. Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon, S.,et al. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163, 1069-1075. doi: 10.1001/archinte.163.9.1069
79. Wang, Y., Yin, H., Wang, L., Shuboy, A., Lou, J., Han, B.,et al. (2013). Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am. J. Chin. Med. 41, 59-70. doi: 10.1142/S0192415X13500055
80. Weih, M., Wiltfang, J., and Kornhuber, J. (2007). Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J. Neural Transm. 114, 1187-1197. doi: 10.1007/s00702-007-0704-x
81. Xiong, S., Markesbery, W. R., Shao, C., and Lovell, M. A. (2007). Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. Antioxid. Redox Signal. 9, 457-467. doi: 10.1089/ars.2006.1363
82. Yang, G., Wang, Y., Tian, J., and Liu, J.-P. (2013). Huperzine a for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS ONE 8:e74916. doi: 10.1371/journal.pone.0074916
83. Yang, X., Dai, G., Li, G., and Yang, E. S. (2010). Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 41, 110-113. doi: 10.1007/s12031-009-9297-1
84. Yehuda, S., Rabinovitz, S., and Mostofsky, D. I. (2005). Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging 26(Suppl. 1), 98-102. doi: 10.1016/j.neurobiolaging.2005.09.013
85. Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A.,et al. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 6, 456-464. doi: 10.1016/j.jalz.2010.01.013
86. Zhang, J., Cao, Q., Li, S., Lu, X., Zhao, Y., Guan, J. S.,et al. (2013). 3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism. Biomaterials 34, 7552-7562. doi: 10.1016/j.biomaterials.2013.06.043
87. Zhang, S., Rocourt, C., and Cheng, W. H. (2010). Selenoproteins and the aging brain. Mech. Ageing Dev. 131, 253-260. doi: 10.1016/j.mad.2010.02.006
88. Zilberter, M., Ivanov, A., Ziyatdinova, S., Mukhtarov, M., Malkov, A., Alpár, A.,et al. (2013). Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. J. Neurochem. 125, 157-171. doi: 10.1111/jnc.12127